Patience isn’t a personality trait. In high-performing concierge practices, it’s a clinical skill — trained, reinforced, and modeled from the top. Here’s what the research says about building the kind of practice […]
Patience isn’t a personality trait. In high-performing concierge practices, it’s a clinical skill — trained, reinforced, and modeled from the top. Here’s what the research says about building the kind of practice […]
By Editor, Concierge Medicine Today History is important to all of us. We learn from it and we many of our futures are shaped by it. A lot has happened in the […]
Membership fees, smaller panels, and a different financial structure entirely. Here’s what physicians need to understand before the math becomes a surprise. CMT Knowledge Library | Educational Reference | Updated April 2026 […]
As the saying goes — and it still holds true — the best physician leaders are readers. By Editor-in-Chief, Concierge Medicine Today My wife has a standing joke in our home: I […]
Turns out AI had a detailed answer. And the model it described is real, federally funded, clinically proven, and already reshaping how acute care gets delivered in America. Published by Concierge Medicine […]
History matters. Not because the past is perfect, but because it is instructive — and because the industry we are part of today was built by real decisions, made by real physicians, […]
Most patient complaints are not about clinical competency. They’re about how patients were made to feel. If your practice isn’t actively managing that gap, you’re not managing your reputation — you’re just […]
A field guide for health system leaders, administrators, and physicians — with verified data, updated program listings, and a clear explanation of the distinctions that matter. By Michael Tetreault, Editor-in-Chief, Concierge Medicine […]
CHICAGO (March 17, 2026) — The American Medical Association (AMA) applauds the introduction of bipartisan legislation to exempt physicians and other health care professionals from the $100,000 filing fee on new H-1B […]
The study, which was designed to evaluate safety and biological effects, enrolled 24 men with high-risk, localized prostate cancer and found that adding the investigational Fc-enhanced anti-CTLA-4 antibody BMS-986218 to hormone therapy […]